ETANERCEPT IN THE REAL CLINICAL PRACTICE OF TREATMENT IN PATIENTS WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITIS
The paper presents the results of an open-label nonrandomized prospective trial, the purpose of which was to evaluate the efficiency and safety of etanercept (ETC) treatment for different forms and variants of active juvenile idiopathic arthritis (JIA) in real clinical practice. The trial included 2...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2013-02-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/1110 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849773698743009280 |
|---|---|
| author | Elena Spartakovna Zholobova O Yu Konopelko O S Rozvadovskaya V Ya Elyashevich M N Nikolayeva |
| author_facet | Elena Spartakovna Zholobova O Yu Konopelko O S Rozvadovskaya V Ya Elyashevich M N Nikolayeva |
| author_sort | Elena Spartakovna Zholobova |
| collection | DOAJ |
| description | The paper presents the results of an open-label nonrandomized prospective trial, the purpose of which was to evaluate the efficiency and safety of etanercept (ETC) treatment for different forms and variants of active juvenile idiopathic arthritis (JIA) in real clinical practice. The trial included 24 patients with JIA. ETC treatment proved to be effective in most patients with a long disease history and a high clinical and laboratory activity who were refractory to conventional antirheumatic therapy. ETC therapy was most effective in patients with the articular form of the disease who showed 100% improvement in at least ACRpedi30 criteria at 6 months of treatment. |
| format | Article |
| id | doaj-art-962c13580dbc4782a235ac8822a3fb17 |
| institution | DOAJ |
| issn | 1995-4484 1995-4492 |
| language | Russian |
| publishDate | 2013-02-01 |
| publisher | IMA PRESS LLC |
| record_format | Article |
| series | Научно-практическая ревматология |
| spelling | doaj-art-962c13580dbc4782a235ac8822a3fb172025-08-20T03:01:58ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922013-02-01511444710.14412/1995-4484-2013-12001050ETANERCEPT IN THE REAL CLINICAL PRACTICE OF TREATMENT IN PATIENTS WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITISElena Spartakovna Zholobova0O Yu Konopelko1O S Rozvadovskaya2V Ya Elyashevich3M N Nikolayeva4Университетская детская клиническая больница Первого МГМУ им. И.М. Сеченова, МоскваУниверситетская детская клиническая больница Первого МГМУ им. И.М. Сеченова, МоскваУниверситетская детская клиническая больница Первого МГМУ им. И.М. Сеченова, МоскваУниверситетская детская клиническая больница Первого МГМУ им. И.М. Сеченова, МоскваУниверситетская детская клиническая больница Первого МГМУ им. И.М. Сеченова, МоскваThe paper presents the results of an open-label nonrandomized prospective trial, the purpose of which was to evaluate the efficiency and safety of etanercept (ETC) treatment for different forms and variants of active juvenile idiopathic arthritis (JIA) in real clinical practice. The trial included 24 patients with JIA. ETC treatment proved to be effective in most patients with a long disease history and a high clinical and laboratory activity who were refractory to conventional antirheumatic therapy. ETC therapy was most effective in patients with the articular form of the disease who showed 100% improvement in at least ACRpedi30 criteria at 6 months of treatment.https://rsp.mediar-press.net/rsp/article/view/1110juvenile idiopathic arthritisgenetically engineered biological agentsetanercept |
| spellingShingle | Elena Spartakovna Zholobova O Yu Konopelko O S Rozvadovskaya V Ya Elyashevich M N Nikolayeva ETANERCEPT IN THE REAL CLINICAL PRACTICE OF TREATMENT IN PATIENTS WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITIS Научно-практическая ревматология juvenile idiopathic arthritis genetically engineered biological agents etanercept |
| title | ETANERCEPT IN THE REAL CLINICAL PRACTICE OF TREATMENT IN PATIENTS WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITIS |
| title_full | ETANERCEPT IN THE REAL CLINICAL PRACTICE OF TREATMENT IN PATIENTS WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITIS |
| title_fullStr | ETANERCEPT IN THE REAL CLINICAL PRACTICE OF TREATMENT IN PATIENTS WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITIS |
| title_full_unstemmed | ETANERCEPT IN THE REAL CLINICAL PRACTICE OF TREATMENT IN PATIENTS WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITIS |
| title_short | ETANERCEPT IN THE REAL CLINICAL PRACTICE OF TREATMENT IN PATIENTS WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITIS |
| title_sort | etanercept in the real clinical practice of treatment in patients with active juvenile idiopathic arthritis |
| topic | juvenile idiopathic arthritis genetically engineered biological agents etanercept |
| url | https://rsp.mediar-press.net/rsp/article/view/1110 |
| work_keys_str_mv | AT elenaspartakovnazholobova etanerceptintherealclinicalpracticeoftreatmentinpatientswithactivejuvenileidiopathicarthritis AT oyukonopelko etanerceptintherealclinicalpracticeoftreatmentinpatientswithactivejuvenileidiopathicarthritis AT osrozvadovskaya etanerceptintherealclinicalpracticeoftreatmentinpatientswithactivejuvenileidiopathicarthritis AT vyaelyashevich etanerceptintherealclinicalpracticeoftreatmentinpatientswithactivejuvenileidiopathicarthritis AT mnnikolayeva etanerceptintherealclinicalpracticeoftreatmentinpatientswithactivejuvenileidiopathicarthritis |